Show simple item record

dc.contributor.authorFrighi, Valeria
dc.contributor.authorAndrews, Tim M
dc.contributor.authorRana, Fareez
dc.contributor.authorStephenson, Matthew T
dc.contributor.authorGoodwin, Guy M
dc.date.accessioned2019-01-08T17:17:03Z
dc.date.available2019-01-08T17:17:03Z
dc.date.issued2018-12
dc.identifier.citationValeria Frighi, Alireza Morovat, Tim M. Andrews, Fareez Rana, Matthew T. Stephenson, Sarah J. White, Emma Fower, Jan Roast, Guy M. Goodwin, 'Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilities', Journal of Intellectual Disability Research (2019). epub ahead of printen
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/158
dc.descriptionCopyright: 2018 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd. Available to eligible users via NHS OpenAthens at https://onlinelibrary.wiley.com/doi/full/10.1111/jir.12581 (login required).en
dc.description.abstractBackground: People with intellectual disabilities (IDs) have very high rates of osteoporosis and fractures, to which their widespread vitamin D deficiency and other factors could contribute. We aimed to assess in people with IDs previously treated for vitamin D deficiency (1) long‐term adherence to vitamin D supplementation and (2) bone mineral density (BMD), as an indicator for risk of fractures, according to vitamin D supplementation and other factors. Method: We recorded height, weight, medical, pharmacological, dietary and lifestyle assessment. Blood sample were taken for vitamin D and related analytes. dual‐energy X‐ray absorptiometry for BMD was performed. Results: Of 51 study participants (mean [standard deviation, SD] age 51.5 [13.6] years, 57% male), 41 (80.4%) were taking vitamin D and 10 were not. Mean [SD] serum vitamin D was 81.3 [21.3] vs. 25.2 [10.2] nmol/L (P < 0.0001), respectively. Thirty‐six participants underwent a dual‐energy X‐ray absorptiometry scan, which showed osteoporosis in 23.7% and osteopenia in 52.6%. Participants on vitamin D had higher BMD than those who were not, a statistically significant difference when confounders (lack of mobility and hypogonadism) were removed. BMD was significantly different according to mobility, particularly in wheelchair users, in whom hip BMD was 33% lower (P < 0.0001) than in participants with normal mobility. Participants still taking vitamin D showed a 6.1% increase in BMD at the spine (P = 0.003) after mean [SD] 7.4 [1.5] years vitamin D treatment. Conclusions: In people with IDs and previous vitamin D deficiency, BMD increases on long‐term vitamin D supplementation. However, additional strategies must be considered for osteoporosis and fracture prevention in this population.en
dc.description.sponsorshipSupported by the NIHR. V. F. holds a grant from the National Institute of Health Research (NIHR) for a study on fractures in patients with IDs. G. M. G. is an NIHR Senior Investigator. The study was funded by the Baily Thomas Charitable Fund.en
dc.description.urihttps://doi.org/10.1111/jir.12581
dc.language.isoenen
dc.subjectIntellectual Disabilitiesen
dc.subjectMobilityen
dc.subjectOsteoporosisen
dc.titleVitamin D, bone mineral density and risk of fracture in people with intellectual disabilitiesen
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record